View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Preventive Medicine News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 03, 2021
1 min read
Save

More patient education needed to ensure proper use of aspirin, statins in older patients

More patient education needed to ensure proper use of aspirin, statins in older patients

Many adults aged at least 75 years are taking aspirin for primary CVD prevention despite lack of evidence, whereas many are not taking statins for primary CVD prevention despite strong evidence, researchers reported.

SPONSORED CONTENT
March 03, 2021
2 min read
Save

WHO: Nearly one in four worldwide will have some hearing loss by 2050

WHO: Nearly one in four worldwide will have some hearing loss by 2050

WHO’s inaugural World Report on Hearing estimates that about one in four people — or about 2.5 billion — worldwide will have some type of hearing loss by 2050.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
March 02, 2021
2 min read
Save

USPSTF: Screen all sexually active women, but not men, for chlamydia, gonorrhea

USPSTF: Screen all sexually active women, but not men, for chlamydia, gonorrhea

The U.S. Preventive Services Task Force issued a draft recommendation encouraging physicians to screen for chlamydia and gonorrhea in all sexually active women aged 24 years and younger.

SPONSORED CONTENT
March 01, 2021
2 min read
Save

Rollout begins for newly approved Johnson & Johnson vaccine

Rollout begins for newly approved Johnson & Johnson vaccine

The White House’s COVID-19 response coordinator said Monday that doses of Johnson & Johnson’s one-shot vaccine will be delivered as early as Tuesday.

SPONSORED CONTENT
February 26, 2021
1 min read
Save

Statins may reduce CV events in older patients with stroke

Statins may reduce CV events in older patients with stroke

Older patients with ischemic stroke who took statins for 2 years after discharge experienced fewer CV events after hospital discharge compared with those who took them for less than 2 years or not at all, researchers reported in Stroke.

SPONSORED CONTENT
February 24, 2021
3 min read
Save

Researchers identify attributes that may differentiate MIS-C from COVID-19

Researchers identify attributes that may differentiate MIS-C from COVID-19

A study involving more than 1,000 patients identified cardiac involvement, age and race as attributes that could differentiate multisystem inflammatory syndrome in children from severe COVID-19, researchers reported in JAMA.

SPONSORED CONTENT
February 19, 2021
2 min read
Save

Q&A: Inpatient mammograms may help reduce screening disparities

Q&A: Inpatient mammograms may help reduce screening disparities

Offering mammograms to low-income, hospitalized women who are overdue to receive one helps reduce barriers to screening that they may face in the outpatient setting, according to researchers.

SPONSORED CONTENT
February 19, 2021
4 min read
Save

Q&A: COVID-19 vaccine makers ramp up testing in children

Q&A: COVID-19 vaccine makers ramp up testing in children

Although the Biden administration has said that enough COVID-19 vaccine doses will be available in the U.S. to vaccinate 300 million people by the end of July, it is still unclear when vaccines will be widely available to children.

SPONSORED CONTENT
February 16, 2021
8 min read
Save

Advocating for change: The power of physicians to give voice to patients

Advocating for change: The power of physicians to give voice to patients

Now is a time of transition in our nation. As physicians, regardless of our background or upbringing, we hold positions of power and privilege in society. We must use our power to give voice to our patients and communities.

SPONSORED CONTENT
February 10, 2021
4 min read
Save

Klisyri superior to placebo for treatment of actinic keratoses in randomized studies

Klisyri superior to placebo for treatment of actinic keratoses in randomized studies

Klisyri, an FDA-approved Src kinase signaling inhibitor, was superior to placebo for the treatment of actinic keratoses, according to findings from two double-blind randomized trials published in The New England Journal of Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails